RenovoRx Current Ratio Growth & History (RNXT)

RenovoRx's current ratio was 4.02 for fiscal 2025.

View full RenovoRx company overview

RenovoRx annual current ratio history

RenovoRx annual current ratio

Fiscal yearPeriod endedCurrent ratioChangeGrowth
20252025-12-314.02−0.08−1.89%
20242024-12-314.102.85+228.66%
20232023-12-311.25−5.34−81.07%
20222022-12-316.59−10.76−62.02%
20212021-12-3117.3616.89+3622.24%
20202020-12-310.47

RenovoRx current ratio trends

Over the last five fiscal years, RenovoRx's current ratio increased from 0.47 to 4.02, a change of 3.56. The latest reported quarter, Q2 2026, shows 5.74.

About the metric

What the current ratio means

The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.

Calculation and source

How the current ratio is calculated

TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review RenovoRx source filings ↗

Community posts

It’s quiet here.

No posts about RNXT yet. Start the conversation.

Write the first post